127 related articles for article (PubMed ID: 6679948)
1. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
[TBL] [Abstract][Full Text] [Related]
2. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
[TBL] [Abstract][Full Text] [Related]
3. Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study).
Dayal B; Tint GS; Shefer S; Salen G
Steroids; 1979 Mar; 33(3):327-38. PubMed ID: 442127
[TBL] [Abstract][Full Text] [Related]
4. Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol and 5beta-cholestane-3alpha, 7alpha, 12alpha, 23xi, 25-pentol.
Shefer S; Dayal B; Tint GS; Salen G; Mosbach EH
J Lipid Res; 1975 Jul; 16(4):280-6. PubMed ID: 1141769
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
Dayal B; Tint GS; Toome V; Batta AK; Shefer S; Salen G
J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722
[TBL] [Abstract][Full Text] [Related]
6. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
Kuramoto T; Suemura Y; Kihira K; Hiraoka T; Hoshita T
Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780
[TBL] [Abstract][Full Text] [Related]
7. Identification of (23S)-5beta-cholestane-3alpha, 7alpha, 12alpha, 23, 25-pentol in cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Kihira K; Kuramoto T
Steroids; 1976 May; 27(5):657-64. PubMed ID: 941184
[TBL] [Abstract][Full Text] [Related]
8. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
Yasuhara M; Kuramoto T; Hoshita T; Itoga E; Kito S
Steroids; 1978 Mar; 31(3):333-45. PubMed ID: 663972
[TBL] [Abstract][Full Text] [Related]
9. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis.
Kihira K; Fukuda K; Kuramoto T; Kuriyama M; Fujiyama J; Osame M; Hoshita T
Steroids; 1991 Sep; 56(9):464-8. PubMed ID: 1805458
[TBL] [Abstract][Full Text] [Related]
10. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis.
Kihira K; Kubota A; Hoshita T
J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531
[TBL] [Abstract][Full Text] [Related]
11. Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study.
Dayal B; Salen G; Tint GS; Toome V; Shefer S; Mosbach EH
J Lipid Res; 1978 Feb; 19(2):187-90. PubMed ID: 632682
[TBL] [Abstract][Full Text] [Related]
12. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
13. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
Setoguchi T; Salen G; Tint GS; Mosbach EH
J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Une M; Kibe A; Itoga E; Kito S; Kuramoto T
J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799
[TBL] [Abstract][Full Text] [Related]
15. Configuration at C-25 in 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25,26-pentol excreted by patients with cerebrotendinous xanthomatosis: circular dichroism and 13C-NMR studies.
Dayal B; Salen G; Toome V; Tint GS
J Lipid Res; 1986 Dec; 27(12):1328-32. PubMed ID: 3559396
[TBL] [Abstract][Full Text] [Related]
16. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
Batta AK; Shefer S; Batta M; Salen G
J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 5 beta-cholestane-3 alpha,6 beta,7 alpha,25,26-pentol and identification of a novel bile alcohol, alpha-trichechol, present in the West Indian manatee bile.
Yoshii M; Une M; Kihira K; Kuramoto T; Hoshita T
Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1852-4. PubMed ID: 2805165
[TBL] [Abstract][Full Text] [Related]
18. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
19. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study.
Kuramoto T; Fukuda K; Ohshima A; Kihira K; Hoshita T
J Biochem; 1994 Apr; 115(4):655-8. PubMed ID: 8089079
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
Batta AK; Salen G; Shefer S; Tint GS; Batta M
J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
